Meeting
2018 ASCO Annual Meeting
A multidisciplinary toxicity team for cancer immunotherapy-related adverse events.
Authors
Jarushka Naidoo
Johns Hopkins Kimmel Comprehensive Cancer Center and Bloomberg-Kimmel Institute for Cancer Immunotherapy, Baltimore, MD
Jarushka Naidoo , Laura Cappelli , Evan J. Lipson , Patrick M. Forde , William Howard Sharfman , Jiajia Zhang , Jenna Mammen , Kendall Moseley , Karthik Suresh , Seema Mehta , Inbal Sander , John Probasco , Alyssa Parian , Rosanne Rouf , Meghan Berkenstock , Patricia Brothers , Joanne Riemer , Leisha A. Emens , Clifton O. Bingham , Julie R. Brahmer
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Health Services Research, Clinical Informatics, and Quality of Care
Track
Quality Care/Health Services Research
Sub Track
Care Delivery/Models of Care
Citation
J Clin Oncol 36, 2018 (suppl; abstr 6538)
DOI
10.1200/JCO.2018.36.15_suppl.6538
Abstract #
6538
Poster Bd #
364
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Annual Meeting
Immune-related adverse events and immunotherapy efficacy in patients with cancer: A retrospective study.
First Author: Lyndsey L Prather
Poster
2021 ASCO Annual Meeting
Real-world outcomes in older adults treated with immunotherapy: A United Kingdom multicenter series of 2,049 patients.
First Author: Anna Claire Olsson-Brown
Poster
2023 ASCO Annual Meeting
Risk of immune-related adverse events (irAE) with immune checkpoint inhibitors (ICI) in patients (pts) with family history (FH) of autoimmune disease (AID).
First Author: Piyush Grover
Poster
2023 ASCO Annual Meeting
Discontinuation of immunotherapy over 2 years for patients with non–small cell lung cancer (NSCLC): A search for predictors.
First Author: Priscilla Cascetta